Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases
CONCLUSION: These findings demonstrate an OS benefit of CRC with multiagent chemotherapy and pinpoint multiple visceral metastases as a potential contraindication for CRC. Although limited by the influence of unmeasured confounders, these findings may inform future prospective investigations into CRC.PMID:38480078 | DOI:10.1016/j.urolonc.2024.02.007
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Vincent E Xu Ryan M Antar Luca Bertozzi Arthur Drouaud Sarah Azari Sean M Lee Michael J Whalen Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Study | Urology & Nephrology